sotorasib
CHEBI:CHEBI_178199
Definition
A pyridopyrimidine that is pyrido[2,3-d]pyrimidin-2(1H)-one substituted by 4-methyl-2-(propan-2-yl)pyridin-3-yl, (2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl, fluoro and 2-fluoro-6-hydroxyphenyl groups at positions 1, 4, 6 and 7, respectively. It is approved for the treatment of patients with non-small cell lung cancer having KRAS(G12C) mutations.
Chemical Information
- Molecular Formula
- C30H30F2N6O3
- Molecular Mass
- 560.606
- Charge
- 0
- SMILES
- CC(C)C1=NC=CC(C)=C1N1C(=O)N=C(N2CCN(C[C@@H]2C)C(=O)C=C)C2=C1N=C(C(F)=C2)C1=C(F)C=CC=C1O
- InChI
- InChI=1S/C30H30F2N6O3/c1-6-23(40)36-12-13-37(18(5)15-36)28-19-14-21(32)26(24-20(31)8-7-9-22(24)39)34-29(19)38(30(41)35-28)27-17(4)10-11-33-25(27)16(2)3/h6-11,14,16,18,39H,1,12-13,15H2,2-5H3/t18-/m0/s1
- InChIKey
- NXQKSXLFSAEQCZ-SFHVURJKSA-N
Alternative Names
- 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-4-[(2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl]pyrido[2,3-d]pyrimidin-2(1H)-one
- AMG 510
- AMG-510
- AMG510
- Lumakras
- sotorasib
- sotorasibum
Drug Classification
-
processed material
-
phenolsView Class →
CHEBI:33853
-
N-acylpiperazineView Class →
CHEBI:46844
-
tertiary amino compoundView Class →
CHEBI:50996
-
monofluorobenzenesView Class →
CHEBI:83575
-
pyridopyrimidineView Class →
CHEBI:38932
-
tertiary carboxamideView Class →
CHEBI:140326
-
methylpyridinesView Class →
CHEBI:25340
-
acrylamidesView Class →
CHEBI:22216
-
t136829
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 2550714
- oboInOwl#hasDbXref
- Wikipedia:Sotorasib
- core#notation
- CHEBI:178199
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- has_treatment
- http://purl.obolibrary.org/obo/DOID_5422
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect10377
- owl#annotatedSource
- t137868
- owl#someValuesFrom
- t3794490
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 2550714
- oboInOwl#hasDbXref
- Wikipedia:Sotorasib
- oboInOwl#id
- CHEBI:178199
- generic_name
- Sotorasib
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT
- listing_expiration_date
- 20241231
- route
- ORAL
- dosage_form
- TABLET, COATED
- marketing_start_date
- 20211117
- package_marketing_start_date
- 06-MAR-20
- labeler_name
- Sigma Aldrich Corporation
- brand_name
- LUMAKRAS
- brand_name_base
- LUMAKRAS
- product_ndc
- 58272-065
- application_number
- NDA214665
- spl_id
- 26b7a962-2f7b-22b3-e063-6394a90a456d
- package_ndc
- 58272-065-01
- package_description
- 70 kg in 1 BAG (58272-065-01)
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_35610
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- core#notation
- CHEBI:178199
- rxcui
- 2687207
- active_ingredient_strength
- 1 kg/1
- upc
- 0355513488020
- manufacturer_name
- Amgen Inc
- active_ingredient_name
- SOTORASIB
- unii
- 2B2VM6UC8G
- spl_set_id
- c80a362c-7ac3-4894-a076-0691e68ef8c1
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class